Staff perceptions following a training programme about reducing psychotropic medication use in adults with intellectual disability: The need for a realistic professional practice framework.
暂无分享,去创建一个
M. Jorgensen | S. Deb | M. Barratt | N. Wilson | M. Donley | M. Buchholtz | B. Limbu | V. Smith
[1] S. Deb,et al. Pharmacological management of psychopathology in people with intellectual disabilities and/or autism spectrum disorder , 2022, BJPsych Advances.
[2] T. Weaver,et al. Causes of and Alternatives to Medication for Behaviours That Challenge in People with Intellectual Disabilities: Direct Care Providers’ Perspectives , 2022, International journal of environmental research and public health.
[3] N. Wilson,et al. Medication oversight, governance, and administration in intellectual disability services: legislative limbo , 2022, Research and Practice in Intellectual and Developmental Disabilities.
[4] V. Cooper,et al. Short-Term Psycho-Education for Caregivers to Reduce Overmedication of People with Intellectual Disabilities (SPECTROM): Development and Field Testing , 2021, International journal of environmental research and public health.
[5] V. Braun,et al. Conceptual and design thinking for thematic analysis , 2021 .
[6] L. Whitehead,et al. Demographic profile of the intellectual disability nursing workforce in Australia: Findings from a national survey , 2020 .
[7] M. Crawford,et al. Short-term PsychoEducation for Carers To Reduce Over Medication of people with intellectual disabilities (SPECTROM): study protocol , 2020, BMJ Open.
[8] Hoe C Lee,et al. Appropriateness of the TOBY Application, an iPad Intervention for Children with Autism Spectrum Disorder: A Thematic Approach , 2019, Journal of Autism and Developmental Disorders.
[9] L. Isherwood,et al. Individualised funding and its implications for the skills and competencies required by disability support workers in Australia , 2019, Labour & Industry: a journal of the social and economic relations of work.
[10] K. Walters,et al. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study , 2015, BMJ : British Medical Journal.
[11] Nigel Beail,et al. Using qualitative methods in research with people who have intellectual disabilities. , 2014, Journal of applied research in intellectual disabilities : JARID.
[12] Robert (Bob) Gates John Gates,et al. An Investigation into the Public Health Roles of Community Learning Disability Nurses. , 2013 .
[13] L. Webber,et al. Disability support workers’ knowledge and education needs about psychotropic medication , 2012 .
[14] T. Iacono. Addressing increasing demands on Australian disability support workers , 2010, Journal of intellectual & developmental disability.
[15] P. Hoekstra,et al. Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription. , 2010, Journal of intellectual disability research : JIDR.
[16] L. Salvador-Carulla,et al. International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities , 2009, World psychiatry : official journal of the World Psychiatric Association.
[17] J. W. Ryan,et al. Medication administration by unlicensed caregivers. A model program. , 2003, Journal of gerontological nursing.
[18] R. Ware,et al. Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study. , 2019, Journal of intellectual disability research : JIDR.